Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

At-the-Market Agreement for PharmaCyte Biotech, Inc.

Represented PharmaCyte Biotech, Inc., a clinical-stage international biotechnology company providing cell and gene therapy solutions, in an “at the market” banking agreement with Chardan Capital Markets, LLC of up to $50 million.